Samsung Pharm (001360) — Free Cash Flow Generation Index

Latest as of June 2022: 0.60x

Samsung Pharm (001360) has a Free Cash Flow Generation Index of 0.60x as of June 2022. Free cash flow of ₩952.48 Million represents 1% of operating cash flow (₩1.59 Billion). See Samsung Pharm (001360) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.60x

Free Cash Flow / Operating CF

Free Cash Flow

₩952.48 Million

KRW

Operating Cash Flow

₩1.59 Billion

KRW

Capital Expenditures

₩638.30 Million

KRW

Samsung Pharm Free Cash Flow Generation Index (2017–2017)

Historical FCF Generation Index trend for Samsung Pharm across 1 annual periods. Explore Samsung Pharm cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Samsung Pharm (2017–2017)

Year-by-year Free Cash Flow Generation Index for Samsung Pharm. For the full company profile including market capitalisation, see Samsung Pharm market cap and net worth.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2017	-0.16x	₩-847.92 Million	₩5.15 Billion	₩6.11 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).